The Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) increased the size of the Board from ten to eleven directors and elected David Wichmann to the Board as a Class I director and Pamela Kimmet to the Board as a Class III director, effective August 1, 2023.
The Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) increased the size of the Board from ten to eleven directors and elected David Wichmann to the Board as a Class I director and Pamela Kimmet to the Board as a Class III director, effective August 1, 2023.
Departed
Jeffrey Bernstein
Director (and Chair of Compensation and Nominating and Corporate Governance Committees)
Jeffrey Bernstein resigned from the Board and as Chair of the Compensation and Nominating and Corporate Governance Committees of the Board, effective August 1, 2023, following Goldman Sachs’ sale of its ownership position in the Company through a secondary offering which closed on May 8, 2023.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
David Wichmann was elected as Director (Class I) at Privia Health Group, Inc..
Action
elected
Role
Director (Class I)
Exact text from the filing
The Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) increased the size of the Board from ten to eleven directors and elected David Wichmann to the Board as a Class I director and Pamela Kimmet to the Board as a Class III director, effective August 1, 2023.
Pamela Kimmet was elected as Director (Class III) at Privia Health Group, Inc..
Action
elected
Role
Director (Class III)
Exact text from the filing
The Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) increased the size of the Board from ten to eleven directors and elected David Wichmann to the Board as a Class I director and Pamela Kimmet to the Board as a Class III director, effective August 1, 2023.
Jeffrey Bernstein resigned as Director (and Chair of Compensation and Nominating and Corporate Governance Committees) at Privia Health Group, Inc..
Action
resigned
Role
Director (and Chair of Compensation and Nominating and Corporate Governance Committees)
Exact text from the filing
Jeffrey Bernstein resigned from the Board and as Chair of the Compensation and Nominating and Corporate Governance Committees of the Board, effective August 1, 2023, following Goldman Sachs’ sale of its ownership position in the Company through a secondary offering which closed on May 8, 2023.
Privia Health Group, Inc.: Increased board size from 11 to 15 directors and removed the office of president (effective 2023-08-01).
Change
bylaw amendment
Effective
2023-08-01
Exact text from the filing
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The Board approved the Company’s Third Amended and Restated Bylaws (as so amended and restated, the “Amended Bylaws”), effective August 1, 2023. The Amended Bylaws permit an increase of the size of the Board from eleven to fifteen directors. The Amended Bylaws also reflect the removal of the office of president from the Amended Bylaws.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.